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Abstract. Tropical infectious diseases diagnosis and surveillance are often hampered by difficulties of sample collec-
tion and transportation. Filter paper potentially provides a useful medium to help overcome such problems. We reviewed
the literature on the use of filter paper, focusing on the evaluation of nucleic acid and serological assays for diagnosis
of infectious diseases using dried blood spots (DBS) compared with recognized gold standards. We reviewed 296 eligible
studies and included 101 studies evaluating DBS and 192 studies on other aspects of filter paper use. We also discuss the
use of filter paper with other body fluids and for tropical veterinary medicine. In general, DBS perform with sensitivi-
ties and specificities similar or only slightly inferior to gold standard sample types. However, important problems were
revealed with the uncritical use of DBS, inappropriate statistical analysis, and lack of standardized methodology. DBS
have great potential to empower healthcare workers by making laboratory-based diagnostic tests more readily accessible,
but additional and more rigorous research is needed.
INTRODUCTION
When performing diagnostic or epidemiological surveys, par-
ticularly in remote areas in resource-poor settings, the facilities
for processing blood andmaintaining frozen samples frequently
do not exist. This finding is especially true for neglected tropi-
cal diseases, because they are frequently in populations remote
from sophisticated diagnostic facilities. Dried blood spots
(DBS) provide a potentially useful and inexpensive means
of overcoming these difficulties. Samples, such as finger-prick
blood, are easily and quickly collected onto filter paper and
shipped at room temperature (even by post). However, blood
sample volumes on filter paper are inevitably small, and there-
fore, rigorous assay validation must be performed to achieve
optimum sensitivity and specificity.
Filter paper was first used as a scientific tool in 1815 by the
Swedish chemist Jo¨ns Berzelius. In the 1940s, Heatley described
the use of filter paper for incorporating antimicrobial solutions
in Oxford, giving rise to antibiotic susceptibility disc testing.1
To overcome the difficulties in collecting blood for standard
diagnostic tests under field conditions in Cuba, Chediak2 devel-
oped a method of identifying syphilis from blood dried on a
glass slide in 1932. However, it was Zimmermann3 at the start
of World War II in Germany who adapted the method by
Chediak2 by drying finger- or ear-prick blood on strips of filter
paper to diagnose syphilis using the microscopic agglutination
test. In 1950, Joe4 in Leiden, The Netherlands received feces
dried onto filter paper by post from Indonesia and was able to
detect Shigella, and in 1961, Anderson and others5 published
methods for detecting Schistosoma antibodies in DBS sent
from endemic areas up to 3 months after collection. Robert
Guthrie is widely credited as being the first to use blood dried
on filter paper (so-called Guthrie cards) to diagnose phenylke-
tonuria in neonates in 1963.6 Since then filter paper has
become a commonly used method of storing and transporting
diverse specimen types from humans, animals, and plants.
Almost all types of human body fluids (from blood to saliva
and feces to breast milk) have been stored on filter paper for a
diverse range of biochemical assays (e.g., newborn screening),
screening for genetic mutations, determination of metabolites
by mass spectrometry, therapeutic drug monitoring, and detec-
tion of nucleic acids, antigens, and serological markers for
infectious disease diagnosis. The recent call for the use of DBS
in diagnostics platforms for the integrated mapping, monitor-
ing, and surveillance of seven neglected tropical diseases and
the World Health Organization (WHO/Joint United Nations
Programme on HIV/AIDS (UNAIDS) Treatment 2.0 initiative
to achieve and sustain universal access to treatment highlights
the need for review of the methodology of DBS preparation,
storage, and elution to ensure best practice.7
Some aspects of the use of DBS in infectious diseases have
been reviewed,8–17 such as for epidemiological studies,15 human
immunodeficiency virus (HIV) detection and monitoring,9–12
virology17 and drug assays.18 However, there are no recent clin-
ically orientated overviews of the use of DBS for the diagnosis
and surveillance of infectious disease.
There are important problems with uncritical use of DBS,
inappropriate statistical analysis, and lack of standardization
of terminology and methodology. We, therefore, reviewed the
literature on the use of filter papers and focused on evaluation
of DBS assays compared with recognized gold standards for
the diagnosis and/or surveillance of infectious diseases for
both nucleic acid amplification tests (NAATs) and serological
assays. Statistical analysis of the studies included in this review
was not performed, because most of the papers cited used
different assays, settings, and reference methods, suggesting
that a meta-analysis would not provide meaningful informa-
tion. We discuss key issues in the preparation, processing, and
storage of DBS and briefly review the use of filter paper with
samples other than blood. Filter paper specimens are also used
for veterinary health, with some overlap with human health.
We, therefore, briefly summarize this parallel work, particularly
for livestock diseases with significant economic impact. We
highlight key difficulties encountered in using DBS, discuss
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the heterogeneity in terminology and methodology used, and
suggest improvements in these areas (Box 1).
RESULTS
Figure 1 depicts the process of study selection for inclusion in
the review. In total, 4,011 potential references were identified, of
which 101 references evaluated DBS against a recognized gold
standard and 192 references assessed the practical aspects of
filter paper use, non-whole blood samples, and veterinary health.
HIV 1 and 2 and HTLV 1. Efforts to make HIV testing
more accessible in rural areas in developing countries, where
> 90% of new HIV infections occur, are critical for controlling
the disease.19 DBS have the potential to provide simple,
robust, and affordable options to collect whole blood for
screening, quality control of point-of-care tests, HIV viral
load measurements, and drug resistance testing in environ-
ments where traditional venous blood collection/transport
cannot be performed.9,11,12,20 Twenty-four studies examined
the use of DBS for detection of HIV compared with serum or
plasma; 12 studies evaluated serological assays, and 12 studies
evaluated NAATs (Supplemental Table A).
Serological assays using DBS samples were evaluated
in 13 diverse countries, thereby probably representing all
HIV-1 subtypes, using third generation enzyme-linked immu-
nosorbent assays (ELISAs) that detect antibodies, fourth
generation ELISAs that detect antibodies and antigens, and
specific antigen tests (p24). The p24 antigen tests are used
as an alternative to NAATs to detect infection in infants
(Table 1). Only one study examined detection of HIV-2
using DBS against serum, reporting sensitivity and speci-
ficity of 87.5% and 100%, respectively.21
DBS have been evaluated for the detection of HIV-1 with
diverse NAATs in 11 countries. Although HIV is an RNA
virus, proviral HIV-1 DNA detection is commonly used for
infant diagnosis. Six studies evaluated the Roche Amplicor and
Roche Cobas Taqman (Basel, Switzerland) assays on DBS,
giving sensitivities and specificities between 97% and 100%
and between 99.6% and 100%, respectively.20,22–26
Most HIV viral load assays use quantitative reverse tran-
scriptase polymerase chain reaction (PCR), which requires
large quantities of plasma (100–600 mL) to transcribe RNA into
DNA before amplification. Other than extracellular HIV-1
RNA amplified from plasma samples, DBS contain whole
blood and therefore, intracellular HIV-1 RNA and HIV-1 pro-
viral DNA. As a result, when HIV-1 viral load assays are used
with DBS, both HIV-1 RNA and HIV-1 DNA will be ampli-
fied, making it potentially more sensitive than HIV-1 DNA
plasma assays. This finding has implications for early detection
of HIV but also, potential overestimation of viral load.
Three studies evaluated the Roche and Abbott (Abbott
Park, North Chicago, IL) NAATs to detect HIV-1 RNA and
DNA in DBS versus whole blood.26–28 The bioMerieux
(Craponne, France) HIV-1 RNA assay cannot amplify HIV-1
DNA. False positive results by quantitative NAATs are a con-
cern when used for qualitative purposes, but these assays
remain a promising alternative for infant diagnosis.20,29 Indeed,
the WHO recommends testing infants for HIV DNA, HIV
RNA, or the ultrasensitive p24 antigen on plasma or DBS
samples given that the sensitivity and specificity of DBS
are > 98%.30 Two papers examined the possibility of detect-
ing human T-lymphotropic virus type I (HTLV-1) serologically
or by in-house NAATs.31,32 Both studies showed good
performance compared with plasma but had relatively small
sample sizes.31,32
Hepatitis viruses. Eight studies evaluated the use of DBS
for the diagnosis of hepatitis viruses (Supplemental Table B).
Three studies evaluated DBS hepatitis C (HCV) serology
against serum or plasma, finding high sensitivity and specific-
ity (> 98%).33–35 Two studies investigated DBS for hepatitis
A (HAV) serology and reported sensitivities > 90% and spec-
ificity approaching 100%.36,37 DBS were also used success-
fully to detect the humoral response to HAV vaccination.37
Only two studies have examined the use of DBS samples for
hepatitis B (HBV) serology, yielding different performances
for three serological HBV assay types, with sensitivities rang-
ing from 78% (for anti-HBs) to 97% (for HBs-Ag).38,39 The
inclusion of combined HCV, HBV, and HIV diagnoses on
one DBS could be a potentially cost-effective way to expand
screening in resource-poor and remote populations.
The detection of HCV and hepatitis E virus by NAATs
seems promising, but more evaluations are needed before
conclusions can be drawn. More evaluation of the optimal
storage DBS conditions for HCV NAAT is required, because
studies have given conflicting results.35,40
Flaviviruses. Capture or sandwich ELISAs are used to
serologically diagnose acute dengue (immunoglobulin M
[IgM] and IgG antibodies and nonstructural protein 1 [NS1]
antigen) and in surveillance and outbreak investigations.
Five studies comparing dengue antibody ELISAs using DBS
and serum reported high sensitivities (> 86%) and specificities
(> 89%)41–45 (Table 2). One study reported poor correlation
of DBS with serum results,44 but the statistical analysis was
inappropriate.46 Antibody titers determined from DBS were
more variable and lower than those titers from sera, suggest-
ing a limited role in the diagnostic confirmation of acute
dengue. All studies concluded that DBS IgG determination
could be used successfully for seroprevalence studies.
Dengue nucleic acid detection from DBS was also highly
sensitive (> 90.7%) compared with serum. The 100% specific-
ity reported by Prado and others47 may reflect the nature of
Box 1.
We searched the electronic databases MEDLINE and Embase
for studies published between 1980 and December 13, 2011.
Publications that evaluated the use of DBS as alternatives
for gold standard samples for human infectious disease
diagnosis were included. We excluded in-house assays for
HIV, Hepatitis B and C, cytomegalovirus, measles, and
rubella because of the existence of well-recognized
commercially available assays for these pathogens. Details
of excluded in-house assays are provided in Supplemental
Table E. During the selection process, studies examining the
practical aspects and implications of using DBS compared
with non-filter paper samples were included. Additionally,
a non-exhaustive selection of studies on the use of filter
paper for samples other than whole blood and animal
pathogens was also identified. We used the following search
terms: dried blood, blood spot,* DBS, dried serum,
serum spot,* filter paper, filter card,* filter disc,* filter disk,*
blotting paper, Guthrie card, Whatman paper, Isocode stix,
FTA*. We made use of corresponding Medical Subject
Heading (MeSH) terms for the above keywords.
Non-infectious neonatal diseases and non-English
publications were excluded. A full review protocol is
provided in Supplemental Appendix 1.
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the samples, which were prepared by spiking whole blood
with dengue virus. Consistent with the period of highest vire-
mia, sensitivity was highest on day 1 of infection and fell
rapidly by day 4. Matheus and others43 found that dengue
RNA could still be detected in dried capillary blood samples
from a small number of patients 12 days after infection,
whereas corresponding venous samples were negative. Dengue
RNA on DBS could be detected after storage at 37°C for
Figure 1. Selection of reports included in the analysis.
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1 year.47 It is important to note that the virus may remain
viable and confers an infective risk during at least the first
48 hours after spotting on untreated filter paper.47
Other viruses. In a seroprevalence study of chikungunya
virus, IgG was successfully detected in DBS with 97.9% sen-
sitivity compared with serum.48 Although IgM was not fully
evaluated on DBS, it seemed to give similar results to those
from sera.48
Three studies evaluated measles antibody (IgM or IgG)
detection using DBS.49–51 Uzicanin and others51 showed that
the sensitivity of DBS compared with serum increased for IgM
from 95.7% for samples collected from days 1 to 6 of the
Table 2
Summary of studies evaluating DBS for Flavivirus and chikungunya diagnosis
Disease,
assay type and country Ref.
Number of
samples/filter
paper type Test Sensitivity (%) Specificity (%) Notes
Dengue serology
Puerto Rico 41 NR/unspecified
filter paper
In-house IgM and
IgG ELISA
97 IgM; 96 IgG 97 IgM; 91 IgG IgM results are for weak positives
(OD = 0.2–0.35).
Vietnam 44 781 patients/
Whatman 903
Dengue fever IgM
and IgG ELISA
(Focus Diagnostics)
NR NR DBS correlated poorly with serum,
particularly for acute 1 °
and acute 2 ° dengue infection.
However, correlation was
inappropriate for analysis.46
Limited role of IgM from DBS for
diagnostic confirmation of dengue
cases. IgG was useful for
seroprevalence studies. No effect
of 1 month storage on results.
Cuba 45 189 patients/
Whatman 2992
In-house ultramicro-
ELISA
92.1 98.6
French Guiana 43 130 patients/
Whatman paper
In-house ELISA IgM 89 94 IgM stable at room temperature for
1 month and at 4 °C for > 2 months.
Nicaragua 42 169 patients/
Whatman No.3
In-house ELISA IgM,
IgA, and IgG
96 IgM; 93 IgA;
86 IgG
89 IgM; 89 IgA;
92 IgG
Detecting IgM or IgA is useful for acute
dengue diagnosis. IgG is optimal
for dengue incidence surveillance.
Danger of cross-reactivity of IgG
with other flaviviruses.
Dengue NAAT
Cuba 47 52 samples/
Nobuto paper
In-house PCR 93 100 Samples prepared with blood spiked
with dengue virus. Lower limit
of detection for dengue serotype 2
than 3. RNA stable at 37°C for 1 year.
Risk of viral infectivity from paper
for 48 hours at room temperature.
French Guiana 45 130 patients/
Whatman paper
In-house PCR 90.7 82.9 Serotyping also performed. Sensitivity
and specificity were highest during
the first 4 days of infection, falling
rapidly thereafter. However, virus
still detectable in 27% up to day 12
in capillary but not venous samples.
Japanese B encephalitis
virus serology
Thailand 161 243 patients/
Nobuto paper
In-house ELISA
and in-house HI
72 and 26/38
and 33 during
epidemic and
non-epidemic
periods
NR ELISA and HI tests were compared
with serum. ELISA was more
sensitive during epidemic periods.
Newer commercially available assays
are available but have so far
not been evaluated on DBS.
Chikungunya serology
La Reunion 48 144 patients/
Whatman 903
IgG ELISA (National
Arbovirus Reference
Laboratory, Lyon,
France)
97.9 100 Seroprevalence study. IgM also
detected with similar OD thresholds
as sera, but no independent quality
control performed.
HI = hemagglutination inhibition; NR = not recorded; OD = optical density.
Table 1
Summary of studies evaluating serological and NAAT diagnosis of HIV comparing DBS with whole blood (DNA) and serum/plasma (RNA)
Assay type HIV-1 detection No. of studies Sensitivity (%) Specificity (%) Refs.
Serology Ab/Ag 7 100 98.7–100 21, 145, 150–154
Serology Ag (p24) 5 84–98.8 98–100 146, 147, 155–157
Serology Western blot 1 92 100 145
NAAT DNA 6 97–100 99.6–100 20, 22–26
NAAT RNA 6 99.2–100 95.6–100 22, 28, 29, 158–160
NAAT DNA and RNA 3 99.7–100 100 24, 26, 27
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illness to 100% when samples were collected 1 week after
the appearance of the rash.51
We found only one study evaluating the use of DBS for
Epstein–Barr virus (EBV) serology. Interestingly, this study
compared venous and capillary blood spotted on two dif-
ferent filter paper types (Whatman 903 and No. 3) for ELISA
(EBNA1 plus VCA-p18) and found similar sensitivities of
75–80% and specificities of 97–100% compared with plasma.52
For the detection of cytomegalovirus (CMV), a serological
assay and an NAAT test were evaluated between plasma and
DBS. The NAAT was 100% sensitive and specific, whereas the
serological assay had lower sensitivity and specificity (both
were > 93%) (Supplemental Table C).53,54 At 4°C DBS stor-
age, measles antibody and EBV IgA and IgG were stable for
at least 24 weeks.49,52
Malaria. For the diagnosis and speciation of malaria, we
found no evaluations of commercially available DBS assays
using PCR in peer-reviewed journals. Two studies compared
PCR on DBS against liquid whole blood and found a lower
sensitivity, particularly for samples with low parasitaemia55,56
(Table 3). DBS PCR compared with microscopy achieves
comparable performance or in some studies, is more sensi-
tive.57 However, DBS PCR has a lower sensitivity than PCR
on whole blood. Because both DBS PCR and microscopy may
miss low-level parasitemia that whole-blood PCR detects,
DBS PCR seems to have a higher specificity than whole-
blood PCR. This result is because of the imperfect nature of
the gold standard of microscopy.56,58 Based on 10 papers
included in this review, malaria detection using the nested
PCR on DBS by Snounou and others59 seemed to be a suit-
able alternative to microscopy. DBS are also commonly used
for detection of malaria resistance molecular markers.60
Parasites. Non-malarial parasites cause many neglected
tropical diseases afflicting hundreds of millions of people,
predominantly in resource-poor regions with limited access
to diagnostic facilities.61 The potential use of filter paper to
aid diagnosis and understanding of the epidemiology of these
diseases is, thus, very attractive. The mapping of lymphatic
filariasis and monitoring of elimination programs provide an
ideal role for DBS. Three recent studies evaluated serological
tests for Wuchereria bancrofti Og4C3 antigen on DBS com-
pared with serum, giving sensitivities of > 93% and specifici-
ties of 82–100%62–64 (Table 4). An early study performed in
Ghana reported a lower sensitivity (50%),65 possibly because
of a difference in strain type (most other studies were per-
formed in Asia), an assay cutoff that was set too high, or
Table 3
Summary of studies evaluating DBS for malaria (malaria NAAT assays)
Country Ref.
Sample size/
filter paper Assay Pf Po Pv Pm Unknown
Sensitivity
(%)
Specificity
(%) Reference test Notes
Thailand 162 56 samples/
Whatman 903
In-house ü 94.6 NR Thin/thick
blood smear
Malaysia 163 166 patients/
Whatman 3MM
In-house
(adjusted)
ü ü 97.4 NR Thick blood
smear
Malaysia 164 129 patients/
Whatman 3MM
In-house ü ü ü ü NR NR Limit of detection:
6 parasites/mL.
Singapore 165 52 patients/
Whatman No.1
In-house ü ü 100 100 Thin/thick
blood smear
Limit of detection:
4 parasites/mL.
Malaysia,
Myanmar,
Thailand
166 81 patients/
Isocode cards
In-house ü ü ü 94.1 (Pf);
100 (Pv)
100 (Pf);
99.1 (Pv)
Thin/thick
blood smear
1 of 1 Po samples
detected.
Thailand 58 136 patients/
Whatman 3MM
Multiplex
PCR
ü ü 100 (Pf);
92.7 (Pv)
100 (Pf);
100 (Pv)
Consensus of
three PCR
assays
Specificity of
all three assays
lower (93.8–97%)
compared with
microscopy.
Microscopy had
90.7–92.5%
sensitivity and
91.5–100%
specificity.
Nested PCR ü ü 100 (Pf);
100 (Pv)
99 (Pf);
100 (Pv)
RT-PCR ü ü 100 (Pf);
100 (Pv)
100 (Pf);
100 (Pv)
Saudi Arabia 55 118 patients/
Whatman paper
In-house ü 73 NR Thin/thick
blood smear
Several microscopy-
negative samples
were positive on
DBS PCR.
Thailand,
Zimbabwe
141 156 patients/
FTA card
In-house ü 97.8 100 Thin/thick
blood smear
Limit of detection:
10 copies/reaction.
Iran 56 75 patients/
DNA Banking
Card
In-house ü ü 97 100 Thin/thick
blood smear
Whole blood was
more sensitive but
less specific than
DBS compared
with microscopy
(100% sensitivity,
95.2% specificity).
Kenya 57 356 patients/
Whatman 3MM
In-house ü 100 79 Thin/thick
blood smear
Low specificity
potentially caused
by insufficient
microscopy
expertise.57
Pf = Plasmodium falciparum; Pm = P. malariae; Po = P. ovale; Pv = P. vivax; RT-PCR = real time PCR; NR = not reported.
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Table 4
Summary of studies evaluating DBS for parasites other than malaria
Disease,
assay type, and country Ref.
Number of
samples/filter
paper type Test Sensitivity (%) Specificity (%) Notes
Lymphatic filariasis:
Wb, Bspp serology
and dipstick
antibody test
94 patients/
Whatman 903
In-house EIA 92 77
India 167
Ghana 65 1,808 patients/
Og4C3 paper
Og4C3 ELISA
(Wb; Tropical
Biotechnology)
50.3 96.4
Sri Lanka 62 60 patients/
Nobotu 1
Og4C3
ELISA (Wb)
97 NR
India 63 30 patients/
Whatman No.3
Og4C3
ELISA (Wb)
76.6–93.3 100 Time of the day at which samples
are collected impacts sensitivity.
India, Egypt,
Haiti, Kenya,
Papua New
Guinea,
Sri Lanka
64 188 patients/
Whatman No.3
Og4C3
ELISA (Wb)
NR NR
Egypt 66 81 samples/filter
paper (Tropical
Biotechnology)
Filariasis (Wb
and Bspp)
CELISA
(Cellabs)
91 (Wb);
98 (Bspp)
NR Based on a panel of known positives.
Uganda 67 66 patients/
Whatman 3MM
Brugia Rapid
(Reszon
Diagnostics)
79 NR Significant cross-reactivity with other
filarial infections.66,67
Lymphatic filariasis:
B. malayi, NAAT
Indonesia 68 36 patients/
Whatman 3MM
In-house PCR
and ELISA
combination
86 NR PCR-ELISA produced comparable
results compared with DNA Detection
Test Strips (Roche, Germany).
Malaysia 69 21 patients/
Whatman 3MM
In-house PCR NR NR
Mansonelliasis NAAT
Brazil 168 12 patients/
Whatman paper
In-house PCR NR NR PCR was able to distinguish between
O. volvulus,M. ozzardi, and
M. perstans.
Loa loa filariasis NAAT
Cameroon 70 68 patients/ NR In-house PCR 96 NR High specificity. No cross-reactivity
with other filarial species. Limit
of detection 1 microfilaria/20 mL
whole blood (as DBS).
HAT serology (card
agglutination test)
Sudan 71 100 patients/ NR Micro-CATT
(ITM Antwerp)
91 NR
Central African
Republic,
Ivory Coast
72 940 patients/
Whatman No.4
Micro-CATT
(ITM Antwerp)
89.4–95.5 95.5–96.6 Truc and others72 report rapid drop
in sensitivity (67.8%) after 3 days
without strict humidity control
of paper. Ranges reported by Truc
and others72 reflect testing at two
different sites.
Chagas disease
serology
Brazil 74 6,222 patients/
Whatman No.1
In-house ELISA,
IF, and HA
ELISA, 78.1;
IF, 69.2;
HA, 64.6
ELISA, 99.7;
IF, 99.4;
HA, 99.6
Brazil 73 24 patients/ NR Chagas Stat-Pak
(ICT; Chembio
Diagnostic Systems)
100 100 Chagas Stat-Pak performed on small
sample size. More sensitive and
specific than large-scale evaluation
with serum.
Echinococcosis
serology
Argentina 76 479 patients/
Whatman No.1
In-house ELISA NR NR Coltorti and others76 report sensitivity
of DBS to be similar to serum.
Uruguay 78 1,149 patients/
Whatman No.1
In-house ELISA NR NR
China 77 2,482 patients/
Whatman No.1
In-house ELISA 96 87
(continued)
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insufficient blood volume spotted onto filter paper. The
CELISA (Cellabs Pty Ltd, Manly, Australia) (W. bancrofti
and Brugia spp.) and Brugia Rapid (Reszon Diagnostics,
Selangor, Malaysia) (Brugia spp.) tests performed on DBS
eluate and compared with serum or plasma proved reasonably
sensitive (71–98%).66,67 Nucleic acid testing was evaluated for
DBS versus microscopy for Brugian filariasis and Loa loa
and seems sensitive, particularly for the latter at 96%.68–70
African and American trypanosomiases have both been suc-
cessfully diagnosed on DBS with high sensitivity and speci-
ficity,71–74 but the sample size for Trypanosoma cruzi was
relatively small.73 Strict control of humidity by storing DBS
in sealed plastic bags with silica gel immediately after drying
may have been a key factor, resulting in the higher sensitivity
reported in the work by Chappuis and others71 compared with
the work by Truc and others.72
PCR testing on DBS for visceral leishmaniasis (Leishmania
infantum) in immunocompromised patients before therapy was
evaluated against bone marrow microscopy in a small series
of patients, yielding a sensitivity of 75%.75 PCR on DBS was
significantly more sensitive than microscopy and culture of
peripheral blood. Campino and others75 suggest a possible role
for PCR on DBS as an initial screening test, potentially avoid-
ing more invasive bone marrow aspiration. Seroprevalence
studies for echinococcosis, fascioliasis, cysticercosis, and toxo-
plasmosis performed well on DBS.76–82 However, antibodies to
cysticercosis decreased rapidly when stored on filter paper.81
Detection of exposure to giardiasis suffered from low speci-
ficity, possibly reflecting cross-reactivity or long-term persis-
tence of antibodies.83,84
Bacteria. There have been few studies evaluating the use of
filter paper to diagnose or determine the seroprevalence of bac-
terial infections compared with viruses and parasites (Table 5).
The success of using both serum and DBS to screen for
leprosy is dependent on the bacillary burden, with multi-
bacillary patients more readily identified.85–87 The commer-
cially available Serodia Leprae particle agglutination test
(Fujirebio, Tokyo, Japan) using DBS had 97.5% concordance
with serum for patients of any bacillary burden.88 Interest-
ingly, the sensitivity of capillary DBS taken from skin smear
sites, such as the earlobe, was slightly but significantly higher
compared with venous DBS and serum. This result may
reflect a higher concentration of antibodies at the site of
infection compared with circulating antibodies.85
Brucella antibodies were eluted from filter paper with diffi-
culty, and correlation coefficients with serum were modest.89
However, correlation coefficients are not valid statistical tests
for comparison of diagnostic methods.46 Serological tests for
other bacterial pathogens, including syphilis, yaws, leptospirosis,
and some rickettsial diseases, performed well on DBS and
could be stored successfully for sufficient periods of time to
allow transport to a laboratory for analysis.90–95
PRACTICAL ASPECTS AND IMPLICATIONS
OF USING DBS SAMPLES COMPARED
WITH TRADITIONAL METHODS
Some of the key neglected but practical aspects that should
be taken into account when using DBS samples are discussed
below (Figure 2).
TABLE 4
Continued
Disease,
assay type, and country Ref.
Number of
samples/filter
paper type Test Sensitivity (%) Specificity (%) Notes
Visceral
leishmaniasis
NAAT
Portugal 75 24 patients/
Whatman No.2
In-house PCR 71–75 NR 15/20 positive for patients not on
treatment and 17/24 if patients on
treatment included. Useful as an
initial screening tool.
Fascioliasis serology
Bolivia 79 68 patients/
Whatman No.1
In-house ELISA NR NR Samples missed on DBS had the
lowest ELISA readings. Samples
stored for 10 years at 4 °C were
successfully detected.
Giardiasis serology
Saudi Arabia 84 147 patients/
Whatman No.4
In-house ELISA 72–96 39–98 al-Tukhi and others84 reported ranges
that depended on ELISA OD
reading and final eluate dilution.
Guimaraes and Sogayar83 had a high
rate of false positives with ELISA.
Brazil 83 133 patients/
Whatman No.1
In-house IF;
in-house ELISA
82; 72 70; 39
Cysticercosis serology
Brazil 80 151 patients/
Whatman No.4
Qualicode
Cysticercosis
ELISA kit
(Immunetics Inc.)
80 NR Good agreement between serum and
DBS. May be a useful initial
screening test. Fall in sensitivity if
filter paper was not frozen after
1 week storage. Ranges were caused
by samples being processed at two
sites using two methods.
Mexico 81 305 patients/
Whatman No. 311
In-house ELISA 39–66 87–96
Toxoplasmosis
serology (latex
agglutination)
United Kingdom 82 273 patients/
Whatman 903
Eiken Toxoreagent
Latex Agglutination
98.8 100
Bssp = Brugia malayi and B. timori; CATT = Card Agglutination Test for Trypanosomiasis; HAT =Human African Trypanosomiasis; IF = Immunofluorescence;Wb =Wucheraria bancrofti.
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Filter paper. There are many different filter paper brands
available consisting of 100% cellulose, and they vary in thick-
ness and pore size. Although many manufacturers produce
cards, only two brands are US Food and Drug Administration
(FDA) -approved for human whole-blood collection (Whatman
903 and PerkinElmer [Beaconsfield, UK] 226 filter papers).
For the Centers for Disease Control and Prevention (CDC)
newborn screening quality assurance program, each lot is
checked to ensure that the relationship between spot size
and whole-blood volume varies minimally.96 When com-
paring 903 and 226 filter papers, < 4–5% difference was
detected for analytes used for neonatal screening.96 FTA
Elute and FTA (Whatman; GE Healthcare, Buckinghamshire,
UK) are treated filter papers that lyse cells and inactivate
antibodies, viruses, and bacteria but allow NAAT assays.
Assays should not be transferred between paper types without
additional evaluation.
Sample collection and storage recommendations.Manufac-
turers’ recommendations as well as the protocols presented by
Mei and others14 and the US CDC97 provide useful guides.
The WHO guidelines for HIV drug resistance testing with
DBS and others contain a more detailed description of how
to collect DBS samples (particularly for RNA viruses).96,98,99
A number of studies also examined HIV DNA and RNA
storage conditions when validating DBS methods.100–103 For
serology, specific collection and storage recommendations
have been produced by the CDC.97
Collecting finger- or heel-prick blood with DBS is a fast
and convenient method that requires minimal training. After
the DBS sample has been dried for at least 3 hours, it should
be stored in a zipped bag with desiccant to reduce humidity
damage. If DBS are stored in freezers, ensure that they are
dried thoroughly after being brought to room temperature to
avoid condensation inside the bag. The effect of long-term
Table 5
Summary of studies evaluating DBS for bacteria
Disease, assay type,
and country Ref.
Number of samples/
filter paper type Test Sensitivity (%) Specificity (%) Notes
Leprosy serology
French Polynesia 86 168 patients/
Whatman No.1
In-house ELISA Multibacillary 96;
Paucibacillary 29
Multibacillary 96;
Paucibacillary 96
India 87 94 patients/
Whatman No.3
In-house ELISA Multibacillary 97;
Paucibacillary 73
Multibacillary 100;
Paucibacillary 100
Based on a cutoff of 1:40
(OD)
India 88 81 patients/
Whatman No.3
MLPA (Fujirebio);
in-house ELISA
67.7 (MLPA);
76.9 (ELISA)
98.7 (MLPA);
83.4 (ELISA);
Nepal 85 200 patients/ NR In-house ELISA NR NR Earlobe capillary blood
more sensitive than
serum or finger-prick
blood85
Orientia tsutsugamushi
and Rickettsia typhi
(scrub typhus and
murine typhus)
Laos 93 53 scrub typhus
patients; 53 murine
typhus patients/
Whatman 903
In-house ELISA 95 IgM and 90 IgG;
91 IgM and
82 IgG
88 IgM and 100 IgG;
100 IgM and
100 IgG
Lower antibody titers
with DBS; storage at
room temperature for
1 month did not affect
antibody titers93,94
Coxiella burnetii,
Bartonella quintana
and Rickettsia conorii
serology
France 94 94 patients/ Fischer
Scientific paper94
In-house ELISA 100 100
Leptospirosis serology
(MAT)
La Reunion 90 52 patients/
Whatman 903
MAT 100 100 DBS samples showed
lower antibody titers
compared with serum
Syphilis serology
United States 91 1,098 patients/
Whatman 903
In-house ELISA 96 94
Tanzania 92 1,037 patients/
Whatman 903
Serodia TPPA
(Fujirebio)
98.3 100
Yaws serology
Papua New Guinea 95 70 patients/
Whatman 903
TPHA–Serodia
TP kit (Fujirebio)
96.5 100 Results unaffected by up
to 2 months storage
Brucella serology
Spain 89 160 patients/
Whatman 2992
Brucella ELISA
(Virotech
System Diagnostika)
NR NR Pearson correlation
coefficient: r = 0.8 for
IgM and IgG; time-
consuming extraction
method
MAT = microscopic agglutination test; MLPA = Mycobacterium leprae particle agglutination; TPHA = Treponema pallidum-specific hemagglutination test; TPPA = Treponema pallidum
particle agglutination test.
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storage at different temperatures on diagnostic accuracy of
DBS has been investigated for only a few pathogens with
variable results (e.g., HCV with poor/uncertain stability35,40
versus dengue, EBV, and measles with better stability).47,49,52
Standardization of experimental methods for assessing DBS
stability would help considerably.
Recording the quality and integrity of filter paper sam-
ples on arrival at the laboratory is essential, as they can vary
because of incorrect blood sampling or environmental factors,
such as humidity, contamination, and mold overgrowth.
The presence of nucleic acids or antibodies in venous and
capillary blood may vary for different pathogens. Two studies
suggest that dengue virus capillary viremia may be more
prolonged than venous viremia,43,104 suggesting that it would
be important, in an evaluation of NS1 assays and NAATs,
that both DBS and liquid blood samples are compared using
capillary blood.
Biosafety issues. Because DBS contain dried blood, regard-
less of the pathogen being investigated, the samples should
be processed as potentially infectious material, and health and
safety regulations should be followed. However, safety and
packaging requirements are simpler than for liquid blood,
and DBS can be shipped as non-regulated, exempt mate-
rials.105 However, although it is believed that bacteria and
viruses have reduced activity when stored as DBS samples,
group A streptococci could still be cultured after elution of
DBS samples, and dengue virus is still viable after 48 hours
on DBS at room temperature.47,106,107 FTA paper carries the
advantage of inactivating highly pathogenic organisms to
allow safe transportation, with reported complete inactivation
of highly pathogenic Avian Influenza Virus (AIV) 1 hour
after adsorption onto FTA paper.108 However, more evalua-
tion of the potential infectiousness of different pathogens on
DBS is needed.
Contamination risks. Manual or automated punch devices,
such as handheld office punches or automated machines (like
the devices used for neonatal screening), are suitable for
removing paper discs from DBS. There is a potential risk of
carryover contamination that can be avoided by cleaning the
punch device with bleach or related products and punching
sterile blank paper between samples. Recently, perforated filter
paper cards have become available (Whatman andPerkinElmer),
allowing the spots to be removed with a pipette tip, obviating the
need for punching machines and reducing contamination risks.
Selecting an assay. For quantitative assays, adjusting the
cutoff for DBS samples compared with whole blood or serum
may improve sensitivity and/or specificity, depending on the
required balance between them.34 Assays that use a relatively
small quantity of plasma/serum that is first diluted with sam-
ple buffer are more suitable for DBS samples than assays
requiring large quantities. Attempts to keep DBS elution
comparable with serum/plasma according to the manufac-
turer’s recommendations will greatly improve the chances
that results of assays on DBS and standard samples will have
comparable accuracy. The quantity of serum in whole blood
dried on filter paper is difficult to determine but essential for
protocol development. Factors, such as hematocrit, blood
volume per spot, and filter paper characteristics, contribute
to different extraction yields of a DBS sample.109
Certain pathogens, such as HIV, are present in large quan-
tities in whole blood (up to 104 copies per drop), whereas
others, such as Salmonella enterica serovar Typhi and Orientia
tsutsugamushi, are present at very low density. DBS as an alter-
native to standard samples is only possible if the pathogen is
present in sufficient numbers for nucleic acid amplification.
Reporting DBS evaluation studies. The Standards for
Reporting of Diagnostic Accuracy (STARD) guidelines110
are an important starting point for assessing DBS evaluations.
Many studies evaluating filter paper do not include full details
on the paper type or processing, key information regarding
reference standards, and use of appropriate statistical tests.
In Table 6, we propose additional points to the current
STARD checklist to address these issues.
USE OF FILTER PAPER FOR SAMPLES
OTHER THANWHOLE BLOOD
Whole blood is the most practical sample to collect on filter
paper; however, many reference assays have used other samples
types (e.g., serum or plasma), and some diseases are preferably
diagnosed using other specimen types (Supplemental Table D).
Evaluation of dried serum spots to detect HAV antibodies
showed a sensitivity and specificity of 100% compared with
liquid serum,111 and HIV ELISA had a sensitivity of 83%.112
Figure 2. Practical aspects and implications of using DBS. NA = nucleic acid.
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NAATs of dried serum spots perform very well for HAV
(92.3% and 100%) and HCV (100% and 100%) sensitivity
and specificity, respectively, versus liquid serum.111,113 Both
hepatitis viruses showed a 10-fold fall in viral load after stor-
age for 4 weeks on paper at room temperature.111,113
Three studies used dried plasma spots and one study used
dried breast milk spots compared with liquid plasma for HIV
quantitative PCR.114–116 HIV RNA on filter paper was stable
at room temperature for > 1 year. Dried buffy coat spots may
be used as a substrate to detect HIV proviral DNA. When
dried on filter paper and compared with liquid samples, there
was 100% concordance between results.117
Although bone marrow is a difficult sample to obtain, it is
the most sensitive substrate for diagnosis of visceral leishman-
iasis. In one small study, 34 of 35 patients suspected of having
the disease on clinical grounds were positive by NAAT on
dried bone marrow spots. This test was more sensitive than
bone marrow microscopy.118
Cutaneous and mucocutaneous samples may be scraped,
aspirated, or directly impressed onto filter paper to diagnose
leishmaniasis and using slit skin smears, leprosy. The sensitivity
of PCR on lesions impressed onto paper for leishmaniasis
ranged from 92.3% to 100% and specificity was 100% compared
with PCR on tissue samples119,120; parasite speciation was also
possible. Mycobacterium leprae was detected by PCR from slit
skin smears on filter paper (60%) in patients with known leprosy
as frequently as from slit skin smears stored in ethanol (58%).121
Sputum and saliva have been more widely examined. Only
67% of serologically positive measles patients were positive
by PCR on dried saliva spots, which were inferior to whole-
saliva and throat swabs.122 Detection of malaria DNA in dried
saliva and dried urine spots was less sensitive than blood
microscopy.123 Dried induced sputum and bronchoalveolar
lavage fluid spots to identify Pneumocystis jirovecii by PCR
had reported sensitivity of 67% and 90–91%, respectively,
compared with microscopic examination of liquid samples.124
Dried cervical smear fluid spots were evaluated for detection
of Human Papilloma Virus by PCR. Concordance of 94–
100% was reported in two of three studies compared with
PCR directly on smear or cytobrush samples.125–127
Dried cerebrospinal fluid (CSF) spots in children with men-
ingitis were assayed by PCR for Streptococcus pneumoniae and
Haemophilus influenzae with a sensitivity of 92% and 70% and
specificity of 99% and 100%, respectively, compared with direct
CSF PCR.128 The detection of cysticercosis antibodies was
less successful, ranging from 52% to 63%, compared with neat
CSF depending on the type of filter paper used to store CSF.81
Both stool and urine have been stored on filter paper. Vib-
rio cholerae could be cultured from dried stool spots after
14 days if humid conditions were maintained129 and was
equivalent to standard transport medium. Viral enteric path-
ogens, including Norovirus, Rotavirus, and Adenovirus sero-
types 40 and 41, were detected by NAAT from dried stool
spots on chromatography paper, with good concordance with
enzyme immunoassay (EIA) performed directly on stool.130–132
Pre-treating the paper with sodium dodecyl sulfate (SDS)/
ethylenediaminetetraacetic acid (EDTA) inactivated the virus,
allowing safe handling of the paper. CMV is readily detected
in urine in viremic patients. Dried urine spots were reported to
have 90% concordance with PCR on DNA extracted directly
from urine.133
USE OF FILTER PAPER IN TROPICAL
VETERINARY HEALTH
Filter paper has been widely used as a specimen substrate
in tropical veterinary health in both livestock and wildlife
diseases. Several zoonotic diseases discussed above, including
echinococcosis, brucellosis, and trypanosomiasis,134 are also
important causes of mortality in other mammals. However,
non-zoonotic diseases are responsible for about one-half of
livestock losses worldwide.134 Poultry, swine, and cattle suffer
the greatest burden of disease, with viruses and parasites
being the major causes. Early warning systems are needed to
detect highly pathogenic organisms, such as AIV. The diffi-
culties of traditional sample collection methods, discussed
above for humans, are equally applicable in the veterinary
setting. Filter paper has played a key role in circumventing
many of these challenges for veterinary medicine. Smith and
Burgoyne135 discuss the problems likely to be faced with the
Table 6
Additional suggested Standards for Reporting of Diagnostic Accuracy (STARD) checklist points for DBS evaluation
Concerns when using DBS STARD checklist adjustments for DBS evaluations
Inconsistency in terminology Make use of clear terminology (i.e., DBS, dried serum spots, dried urine
spots, etc. or dried “sample type” spots).
Unclear or not reporting filter paper sample collection method Sample collection: state the filter paper brand and weight used,
which and how fluids were obtained and spotted onto filter paper,
and the drying period before storage.
Unclear reporting of reference method and sample Report the index sample and its collection, storage, and transportation
details; provide detailed rationale for discordances in methods between
index and reference test.
Unclear or not reporting storage and time between collecting
and analyzing samples
Sample processing: state the time and storage conditions (humidity
control and temperature) in the field, during transportation, and in the
laboratory, preferably in a tabled manner.
Unclear or not reporting punch method and punch disinfection
procedure
Report punching method with reference to source or manufacturer and
punch disinfection procedure if used.
Unclear or not reporting how quantitative data was obtained
from filter paper samples
For quantitative or numerical test results, indicate the calculation methods
and rationale of the index and reference standard.
Unclear or not reporting the biological variability of samples
and mean difference between index and reference sample
For quantitative test outcomes, report the mean and range of results for
index and reference test.
Unclear or not reporting of diagnostic accuracy of quantitative
test outcomes.
For quantitative test outcomes, estimates of diagnostic accuracy and
measures of statistical uncertainty (e.g., 95% confidence intervals) by
quantitative grouped ranges (e.g., 1,000–5,000 copies/mL).
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use of filter paper (FTA) with veterinary samples. Leishman-
iasis is an important zoonosis with reservoirs in canids; how-
ever, serological studies among dogs using filter paper
compared with serum have given relatively poor sensitivity of
22.2% or agreement of 68.8% (k = 0.234).136,137
DISCUSSION
Over the last 50 years, filter paper has gained an increas-
ingly important role as a substrate for the diagnosis and sur-
veillance of infectious diseases. Recently, this role has gone
beyond diagnosis to include detection of markers of resistance,
detailed genetic or serological analysis, and monitoring of ther-
apeutic interventions, including drug levels, vaccine-induced
responses, and viral loads.
Almost any clinical sample may be stored on filter paper
for subsequent analysis, although finger-prick blood is the
most convenient and widely used. Point-of-care tests are
increasingly providing a key role in diagnosing and surveying
infectious diseases in remote settings, and affordable micro-
fluidics devices based on paper to diagnose infectious diseases
are promising tools.138
Viruses, particularly HIV, have been most frequently
targeted with filter paper diagnostics. Serological tests per-
form very well, with seven studies reporting sensitivity and
specificity close to 100%. NAAT performance is more vari-
able because of the greater instability of nucleic acids, but
mostly, it reached similar diagnostic accuracy. Infant diag-
noses using both RNA and DNA are feasible; however, RNA
tests tend to suffer from reduced specificity. Hepatitis viruses,
many of the Herpes virus family, measles, and rubella also
perform well with serological tests, with sensitivities and spec-
ificities of > 90%. NAATs seem promising, although more
evaluations are needed, particularly for HCV and HEV. Den-
gue serology performed on DBS is clearly suitable for sero-
prevalence studies, although it is less clear for the diagnosis
of acute primary and acute secondary infections. Dengue
serotyping is epidemiologically important and can also be
successfully performed from DBS.43,139
DBS also play a key role in the diagnosis of parasitic infec-
tions. Detection of malaria by PCR using in-house methods is
generally superior to microscopy. Most studies report sensitiv-
ities of > 94% and specificities of > 99%.56,58,140,141 Because of
the prevalence of filariasis in remote settings, filter paper has
been used in the diagnosis and investigation of epidemiology
and response to eradication programs. Using commercially
available assays, sensitivities of > 90% may be achieved.62,66
Leishmaniasis, cysticercosis, and giardiasis have proved to
be less promising in the few studies that have evaluated
DBS compared with a recognized gold standard.75,81,83 Sero-
logical tests for leptospirosis, treponemal infections, and some
rickettsia have yielded excellent results,90,92,94 whereas others,
such as brucellosis, have been less successful.89
The selection of pathogens that may perform well on filter
paper is dependent on several important factors, crucially the
presence and quantity of serological markers and nucleic
acids in the blood at the time of sample collection, their sta-
bility on filter paper, and the elution method that maximizes
test performance with DBS.
There are several key advantages of using filter paper over
the traditional specimens of whole blood or serum. Many of
the pathogens discussed above are most common in remote
and resource-poor settings with limited access to advanced
diagnostic facilities. Filter paper obviates the need for a
cold chain to preserve specimens in transport to a central
laboratory, thus enormously increasing the accessibility of
these tests. Filter paper is generally cheap (although some
of the treated papers, such as FTA, are very expensive),
requires only a small sample volume, and needs minimal tech-
nical expertise to perform. These factors are likely to make
sample collection more acceptable to the patient and less
of a burden for the health system, and they will probably
increase testing uptake.142 Filter paper is easily and safely
delivered using almost any existing transportation network.
Recent advances in chemically pre-treated cards have pro-
vided increased safety in handling and transporting samples.108
Filter paper has been used with multiplex serological and
NAATs to diagnose combinations of Hepatitis B, C, and
HIV,143,144 increasing the diagnostic potential of a single DBS.
There are, however, important difficulties and limitations
in the evaluation of filter papers as diagnostic tools. A great
variety of terminology has been used, and studies evaluating
the same pathogen often use different methodologies
encompassing almost every stage of the process from filter
paper selection to final assay procedures, making comparison
vexed. Some studies have used DBS without justifying that
the method is accurate against a reference standard. Many
filter paper varieties have been used (products are not always
clearly labeled with the paper weight in grams per meter2),
and sample volumes will vary; therefore, care is required
when moving techniques between paper types. A consensus
document on terminology and methodology would be invalu-
able for advancing the field of filter paper diagnostics. Sur-
prisingly, there have been no cost-effectiveness analyses of
the use of filter paper for infectious disease diagnostics.
Human and animal health are inextricably linked, but there
has been very little, if any, collaboration between scientists
and health workers interested in human and non-human
health and filter paper diagnostics. More One Health collab-
oration on these techniques would benefit both fields.
High temperatures and humidity over prolonged periods
severely reduce test sensitivity, particularly for NAATs,
although this finding seems to vary between patho-
gens.35,47,145–147 Inevitably, the volume of blood per spot will
be less than the volume of a whole-blood sample collected by
venipuncture. DBS containing whole blood may also influence
NAATs or serological assays because of the presence of inhibi-
tors. They can, however, be overcome by DBS-specific proto-
cols.148,149 Although some guidelines exist, there is an urgent
need for more robust standardized protocols for sampling,
storage, processing, and evaluating filter paper techniques.
Of the studies reported in this review, 42% of them were
not prospective, real-life evaluations; such studies would pro-
vide a stronger evidence base to support recommendations.
Additionally, most studies used pipettes to spot venous blood
onto filter paper, giving a greater consistency in blood
volume than direct application of blood to paper. How-
ever, this consistency is unlikely to be achieved with field
samples. A number of studies did not report sensitivity and
specificity, and several studies inappropriately used corre-
lation coefficients.46 The inclusion of additional reported
items to improve accuracy and completeness of filter paper
studies could greatly improve consistency and clinical use
of the results (Table 6).
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Our review has important limitations. We only included
studies published in English, excluded related subjects, such
as filter paper assays of drug resistance and viral loads, excluded
in-house assays for those diseases with well-recognized com-
mercially available assays, and did not do a detailed assess-
ment of veterinary use of filter paper (this assessment would
require a literature review in its own right).
This work is a first attempt to summarize the subject of
filter paper diagnostics in tropical diseases. We highlight the
many advantages that filter paper offers over traditional sam-
ples and discuss the associated limitations and difficulties.
Consensus should be reached regarding the methodology
and terminology used to better advance this important diag-
nostic tool. Filter paper has been shown to be a valuable asset
in increasing accessibility, making affordable, robust, sensitive,
and specific diagnostic testing available to patients in remote
settings. Its use in surveillance of neglected tropical diseases
targeted for elimination and potentially, veterinary pathogens
makes DBS an important tool in international health.
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